Mesa Laboratories (MLAB) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.71
- Estimate
- $2.24
- Surprise
- -23.5%
- Revenue (period 2026-09-30)
- $62.3M
- Score today
- 4.9/10
Revenue source: xbrl.
How the report landed
Mesa Laboratories (MLAB) missed the $2.24 estimate with adjusted EPS of $1.71 — a large 23.5% shortfall.
Coverage in the report window
- Mesa Laboratories Sees FY2027 Sales $250.000M-$255.000M vs $254.450M Est — benzinga, 2026-11-09
- Mesa Laboratories, Inc. Announces Second Quarter Fiscal Year 2027 Results and Issues First Full-Year Guidance — fiscal.ai, 2026-11-09
- Mesa Laboratories Q2 2027 Earnings Call Transcript — benzinga, 2026-11-09
Where TrendMatrix's rating stands now
TrendMatrix currently rates MLAB Sell at 4.9/10; no pre/post engine snapshot brackets this report.
2 of the last 4 quarters beat the estimate; this quarter's -23.5% surprise compares with a -5.3% four-quarter average.
What supports the rating
- Positive insider activity
What argues against it
- Concentration risk — Product: Clinical Genomics consumables (80.0%)
- Analyst target reached - limited upside remaining
- V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $136.69
- Stop
- $127.13
The stock trades at 150.4× trailing but 12.4× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-11-10 — shown for context, not personalized investment advice.
MLAB at TrendMatrix's latest read
Technology names get repriced on forward expectations more than trailing prints — a quarter here is read through next-year growth and multiple, not the EPS line alone.
- Industry
- Scientific & Technical Instruments
- Market cap
- $715.3M
- P/E (fwd)
- 12.4
- P/E (ttm)
- 150.4
- 52-week range
- $69.51–$144.35
- Off 52-week high
- 5.3%
- RSI (14)
- 58
- Volume vs avg
- 1.08×
- Score today
- 4.9/10